Skip to content
Home/Companies/Healthcare/Achilles Therapeutics

Achilles Therapeutics

Healthcare·United Kingdom·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns Achilles Therapeutics?

Achilles Therapeutics was owned by Albion Capital through Albion Enterprise VCT (2007 vintage) from 2016 to 2021, exited via IPO.

Hand-verified · updated 2026-06-07

Albion Capital
Investor
Albion Capital
Albion Enterprise VCT · 2007 · Evergreen

Key facts

HQUnited Kingdom
SectorHealthcare
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2021

More from Albion Enterprise VCT

Other portfolio companies in the same fund.

Bound
Active
FintechUnited Kingdom· 2026
Firenze
Firenze
Active
FintechUnited Kingdom· 2026
Flok Health
Active
HealthTechUnited Kingdom· 2026
Gaussion
Active
ClimateTechUnited Kingdom· 2026
geoSurge
Active
AI/MLUnited Kingdom· 2026
Agio Ratings
Active
FintechUnited Kingdom· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Achilles Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Achilles Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue